Cite

HARVARD Citation

    Reshef, A. et al. (n.d.). Recombinant human C1 inhibitor for the prophylaxis of hereditary angioedema attacks: a pilot study. Allergy. 68 (1), pp. 118-124. [Online]. 
  
Back to record